-+ 0.00%
-+ 0.00%
-+ 0.00%

AVALYN ANNOUNCES ADDITIONAL LONG-TERM DATA ON AP01, INHALED PIRFENIDONE, FOR THE TREATMENT OF PULMONARY FIBROSIS TO BE PRESENTED AT THE EUROPEAN ALLIANCE OF ASSOCIATIONS FOR RHEUMATOLOGY 2026

Reuters·05/21/2026 12:00:00

Please log in to view news